FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause May 30, 2018 No Comments
European Commission grants authorization to Rubraca for recurrent ovarian cancer May 30, 2018 No Comments
FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis May 29, 2018 No Comments
FDA approves Briviact oral formulations for the treatment of pediatric patients May 15, 2018 No Comments
FDA approves Myrbetriq in combination with solifenacin for overactive bladder May 8, 2018 No Comments
RSS